Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Go back to Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data
(NASDAQ: SNDX) Delayed: 19.32 --0 (-0%)
Previous Close $19.32    52 Week High $18.03 
Open $19.32    52 Week Low $8.97 
Day High $19.32    P/E N/A 
Day Low $19.32    EPS $0.00 
Volume 100